期刊文献+

术中应用卡前列素氨丁三醇与缩宫素在预防宫缩乏力中的应用效果研究

Application Effect of Carboprost Tromethamine and Oxytocin in the Prevention of Uterine Atony and Perinatal Risk Management Measures
下载PDF
导出
摘要 目的:探讨术中应用卡前列素氨丁三醇与缩宫素在预防宫缩乏力中的效果及围产期风险管理措施。方法:选取我院120例采用剖宫产手术分娩的产妇作为研究对象,采用随机数字表法将其分为观察组与对照组,各60例,对照组术中采用静脉注射缩宫素及宫体注射卡前列素氨丁三醇,观察组则基于风险管理指导术中应用卡前列素氨丁三醇及缩宫素,比较两组宫缩乏力预防效果及术后出血情况。结果:观察组产妇产后出血发生率明显低于对照组(P<0.05),观察组产妇术中、术后2 h、术后24 h出血量以及止血时间均明显低于对照组(P<0.05),并且观察组对围手术期护理服务满意度明显高于对照组(P<0.05)。结论:基于风险管理指导术中应用卡前列素氨丁三醇及缩宫素可有效治疗剖宫产术后宫缩乏力,降低术后出血风险,具有临床应用及推广价值。 Objective:To investigate the effect of intraoperative application of carproterin and oxytocin in the prevention of uterine inertia and perinatal risk management measures.Methods:120 cases of puerpera in our hospital were selected as the research object.All the pregnant women were given cesarean section.They were randomly divided into observation group and control group with 60 cases in each group.The control group was treated with intravenous oxytocin and intrauterine injection of carboprost tromethamine to prevent postoperative hemorrhage of uterine atony.Results:The incidence of postpartum hemorrhage in the observation group was significantly lower than that in the control group(P<0.05).The intraoperative blood loss,2-hour blood loss,24-hour blood loss and hemostasis time in the observation group were significantly lower than those in the control group(P<0.05),and the nursing satisfaction of the observation group was significantly higher than that of the control group(P<0.05).Conclusion:The application of carboprost tromethamine and oxytocin can effectively reduce uterine atony after cesarean section under the guidance of risk management.
作者 熊娜 XIONG Na(Obstetrics,Jiangxi Maternal And Child Health Hospital,Nanchang Jiangxi 330100,China)
出处 《药品评价》 CAS 2020年第18期26-28,共3页 Drug Evaluation
关键词 卡前列素氨丁三醇 缩宫素 宫缩乏力 术后出血 围产期风险管理措施 Carboprost Tromethamine Oxytocin Uterine Atony Postoperative Bleeding Perinatal Risk Management Measures
  • 相关文献

参考文献9

二级参考文献87

  • 1熊轲.应用欣母沛预防和治疗宫缩乏力性产后出血的时机探讨[J].当代医药论丛,2014,12(7):256-257. 被引量:6
  • 2华绍芳,薛凤霞.妇科围术期的输液输血治疗[J].中国实用妇科与产科杂志,2007,23(3):168-171. 被引量:10
  • 3陈敦金,许波.产科失血性休克的血流动力学监测及补液治疗[J].中国实用妇科与产科杂志,2007,23(3):171-173. 被引量:18
  • 4孙一勤.欣母沛治疗宫缩乏力性产后出血的疗效观察和护理[J].护理研究(中旬版),2007,21(4):997-998. 被引量:12
  • 5丰明生.催产素预防产后出血的临床观察.中外健康文摘,2008,5(6):81-81.
  • 6Carroll O,Cuesta O,Abalos E,et aI.Epidemiology of postpartum haemorrhage:a systematic review[J].Best Pract Ees C].in Obstet Gynaecol,2008,22:999-].012.
  • 7Gibbins KJ,Albright OM,Pouse DJ.Postpartum hemorrhade in the developed world: whither misoprotol?[J]. Am J Obstet Oynecol, 2013,208 181 - ]. 83.
  • 8Higgins L,Mechery J,Tomlinson AJ.Does carbetocin for prevention of postpartum haemorrhage at caesarean section provide clinical or financial benefit compared with oxytocin?[J].J Obstet Gynaecol, 2011,31:752-759.
  • 9Vaid A,Dadhwal V,Mittal S,et aI.A randomized controlled trial of prophylactic sublingual misoprostol versus intramuscular methyl ergometrine versus intramuscular 15 methyl PGF 2alpha in active management of third stage of labor[J].Arch Gynecol Obstet, 2009,280:895-897.
  • 10Eoach MK,Abramovici A,Tita AT.Dose and duration of oxytocin to prevent postpartum hemorrha6e:a review[J].AM J Perinatol, 2013,50(7). 523-528.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部